Andrew Retter - Nov 1, 2025 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role
Chief Medical Officer
Signature
/s/ Andrew Retter
Stock symbol
VNRX
Transactions as of
Nov 1, 2025
Transactions value $
-$1,991
Form type
4
Date filed
11/4/2025, 04:01 PM
Previous filing
Aug 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Retter Andrew Chief Medical Officer 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON /s/ Andrew Retter 2025-11-04 0002015252

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Tax liability -$1.99K -4.59K -3.04% $0.43 147K Nov 1, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F2 Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 9,762 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.